Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Molecular Biology Pharmaceutical-composition-containing-bile-acid-sequestrant-enclosed-in-a-size-exclusion-membrane

 Glycopetide antibiotic PA-45052-B
OF THE INVENTION The present inventors found that the strain belonging to the genus Nocardia ...


 Production of pure sugars and lignosulfonates from sulfite spent liquor
According to the present invention, sulfite spent liquor is subjected to a two-step chromatographic ...


 Chromatographic separator sorbent bed preparation
This invention provides a sorbent bed packing procedure which minimizes sorbent bed compartment ...


 Simulated moving bed chromatographic separation
What is claimed is: 1. In a method for the separation of an extract component from a raffinate ...


 Method for fractionating sulphite cooking liquor
We claim: 1. A method for the fractionation of sulphite cooking liquor by a sequential ...


 Method for cloning and producing the Msel restriction endonuclease
OF THE INVENTION In one embodiment, the present invention relates to a method of producing a ...


 Xanthine oxidase
I claim: 1. A milk xanthine oxidase active enzyme concentrate having an average protein to flavin ...


 Silver halide photographic light-sensitive materials
Accordingly, an object of the present invention is to provide highly sensitive silver halide ...


 Ligand analog-irreversible enzyme inhibitor conjugates and methods for use
OF THE INVENTION The present invention relates to methods and reagents for determining ligands in ...


 Rapid assaying method for guanase
What we claimed is: 1. In the method of assaying guanase in the sample of the body fluid by adding ...


 Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane

Details
Inventors: Imondi, Anthony R.; Hagerman, Larry M.;
Assignee: Erbamont Inc. (MN)
Primary Examiner: Page; Thurman K.
Assistant Examiner: Webman; E. J.
Attorney, Agent or Firm: Thompson, Hine and Flory

A pharmaceutical composition useful for treating hypercholesterolemia comprising a bile acid sequestrant resin such as cholestyramine and cholestipol maintained in a semipermeable water-insoluble material; wherein said semipermeable material enables bile acids from the digest tract to contact and bind to said resin while preventing substances having a higher molecular weight than bile acids from contacting said resin material. A method for treating hypercholesterolemia using the inventive composition is also disclosed.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT In describing the preferred embodiment, certain terminology will be utilized for the sake of clarity.
It is intended that such terminology include not only the recited embodiment, but all technical equivalents which operate in a similar manner, for a similar purpose, to achieve a similar result.
The present invention relates to a pharmaceutical composition useful for treating hypercholesterolemia comprising a bile acid sequestrant resin maintained in a semipermeable or microporous water-insoluble material; wherein said semipermeable or microporous material enables bile acids from the digestive tract to contact and bind to said resin while preventing substances having a molecular weight greater than bile acids from contacting said resin material.
The active material according to the present invention is a bile acid sequestrant resin.
These resins, which are solid and typically granular in form, function to reduce the blood cholesterol level in humans using the above described mechanism.
One resin which may be utilized as a bile acid sequestrant comprises a cholestyramine resin.
The particle size of the resin typically ranges from about 100 to about 200 mesh.
Cholestyramine is commercially available and sold by a number of drug manufacturers.
An example of a commercially available cholestyramine resin is Questran, sold by Bristol Labs.
Another bile acid sequestrant resin which has been commonly employed is colestipol.
This material is also commercially available and is sold in granular form by the Upjohn Chemical Company under the name Colestid.
Cholestyramine is the bile acid sequestrant resin of choice.
The sequestrant resin is maintained in a nondegradable membrane which may be a semipermeable or microporous material.
This material is particularly characterized by being capable of enabling bile acids from the digestive tract to contact and bind to the resin while preventing substances having a molecular weight greater than bile acids (e



Related patents
  Process for the preparation of insecticidal, nematicidal and acaricidal 2-halo-3-substituted-5-arylpyrrole compounds
OF THE INVENTION One of the preferred embodiments of the present invention involves reacting a formula II substituted acetonitrile compound as described above with at ...
  Transparent impact polymers
OF THE INVENTION The monomers of the feed mixture of this invention are selected from three specific types and may include a fourth type. Monomer (a) is a styrenic ...
  Oil reclaimer
I claim: 1. An apparatus for removing impurities from lubricating oil, comprising, a container having upper and lower ends, said container having an oil inlet opening ...
  Visual-type hygrometer
What is claimed is: 1. The complexes of the alkali metals salts of 3,3',4,4' benzophenone tetracarboxylic acid in which the alkali metal salt is complexed with from 0.5 ...
  Plant watering indicator
I claim: 1. Apparatus for indicating when a plant requires to be watered comprising, a member insertable into the soil, said member having a layer of hygroscopic ...
  Affinity detection apparatus
In the immunoassay apparatus disclosed herein, the coated member and well have complimentary shapes so as to define a thin passageway between the member and well along ...
  Sulfide containing tin stabilizers
What is claimed is: 1. A monoorganotin or diorganotin mercaptoalkyl ester of a carboxylic acid or mercapto hydroxyalkyl ester of a carboxylic acid mono or poly sulfide ...
  Method for enzyme reutilization
OF THE INVENTION Waste materials containing cellulose which have previously been disclosed as potential sources for degradation to simple organic molecules with the ...
  Compounds that bind to digitalis receptor
What we claim is: 1. A C3-glycoside derivative of a 14.beta.-hydroxypregnane and having the formula: ##STR9## wherein GLY is a glycoside radical selected from the group ...
  Reticulated cellulose and methods and microorganisms for the production thereof
The present invention includes a reticulated bacterial cellulose product having novel properties. This reticulated bacterial cellulose product is characterized by a ...

0.024

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved